Your browser doesn't support javascript.
loading
bITH, a blood-based metric of intratumor heterogeneity, is associated with clinical response to immune checkpoint blockade in non-small cell lung cancer.
Fan, Yun; Liu, Yang; Wang, Liuchun; Cai, Yiran; Cao, Wen; Sun, Wenjie; Zou, Xiao; Li, Bing; Zhang, Zhou; Cai, Shangli; Chuai, Shannon; Han, Yusheng; Pan, Xiaojie; Huang, Dingzhi.
Afiliação
  • Fan Y; Department of Medical Thoracic Oncology, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, China.
  • Liu Y; Department of Pathology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, China.
  • Wang L; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Cancer Institute & Hospital, Tianjin Medical University, China.
  • Cai Y; Burning Rock Biotech, Guangzhou, China.
  • Cao W; Department of Oncology and Hematology, The Second Hospital of Hunan University of Chinese Medicine, China.
  • Sun W; Burning Rock Biotech, Guangzhou, China.
  • Zou X; Burning Rock Biotech, Guangzhou, China.
  • Li B; Burning Rock Biotech, Guangzhou, China.
  • Zhang Z; Burning Rock Biotech, Guangzhou, China.
  • Cai S; Burning Rock Biotech, Guangzhou, China.
  • Chuai S; Burning Rock Biotech, Guangzhou, China.
  • Han Y; Burning Rock Biotech, Guangzhou, China.
  • Pan X; Department of Thoracic Surgery, Fujian Provincial Hospital, China. Electronic address: pxj1028@hotmail.com.
  • Huang D; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Cancer Institute & Hospital, Tianjin Medical University, China. Electronic address: dingzhih72@163.com.
EBioMedicine ; 91: 104564, 2023 May.
Article em En | MEDLINE | ID: mdl-37094467

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China